$DVAX News Article - TriSalus Life Sciences Acquires Dynavax's SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales https://marketwirenews.com/news-releases/tris...16601.html
(0)
(0)
Dynavax Technologies Corp. (DVAX) Stock Research Links